Shares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have been given an average recommendation of "Moderate Buy" by the sixteen ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three